-
Angio Dynamics EPS $0.15 Vs. $0.12 (ANGO)
Tuesday, April 5, 2011 - 4:03pm | 14Angio Dynamics EPS $0.15 Vs. $0.12 (NASDAQ: ANGO).
-
Mid Afternoon Top-5 and Bottom-5 Percentage Gainers (NSM, ISPH, MRK, QCOR, PK, AAU, DGW, LEDS, MERU, WMGI, ZSTN)
Tuesday, April 5, 2011 - 1:54pm | 425The top-5 and bottom-5 percentage gainers in trading action thus far are: Best 1) National Semiconductor (NYSE: NSM): A bid from Texas Instruments to buy the company for $25 a share has the stock up a monstrous 71.57% to $24.14. 2) Inspire Pharmaceuticals (NASDAQ: ISPH): After a trading halt,...
-
Top-5 and Bottom-5 Percentage Gainers This Morning (NSM, QCOR, CBST, SCEI, ISIL, DGW, MERU, LEDS, TRBR, WMGI)
Tuesday, April 5, 2011 - 10:24am | 410The indices all opened to the downside this morning on news that China raised interest rates overnight. The increase is China's fourth since October and is meant to curb increasing inflation. US markets are assessing the effect the hike will have on commodity prices and exports to the economic...
-
Earnings Preview For AngioDynamics (ANGO)
Tuesday, April 5, 2011 - 9:04am | 240AngioDynamics Inc. (NASDAQ: ANGO) will be reporting 2011 fiscal third-quarter results after the bell today. Analysts are expecting the company to report a profit of $0.12 per share versus $0.13 in the year ago period. Revenues are slated to come in at $53.89 million. Earnings estimates have ticked...
-
Wright Medical Falls 7.8% As Trading Resumes (WMGI)
Tuesday, April 5, 2011 - 9:03am | 16Wright Medical Falls 7.8% As Trading Resumes (NASDAQ: WMGI)
-
Trading Resumes: Wright Medical Group (WMGI)
Tuesday, April 5, 2011 - 9:00am | 15Trading Resumes: Wright Medical Group (NASDAQ: WMGI)
-
CryoLife Commences Tender Offer for All Outstanding Shares of Cardiogenesis Corporation
Tuesday, April 5, 2011 - 8:38am | 157CryoLife, Inc. (NYSE: CRY) announced today that it, through its wholly-owned subsidiary CL Falcon, Inc., has commenced a cash tender offer for all outstanding shares of Cardiogenesis Corporation (CGCP) common stock. The tender offer is being made pursuant to the previously announced definitive...
-
Boston Scientific Begins International Clinical Trial Enrollment for INNOVA Self-Expanding Bare-Metal Stent System
Tuesday, April 5, 2011 - 8:36am | 103Boston Scientific Corporation (NYSE: BSX) today announced the start of patient enrollment in the SuperNOVA clinical trial, an international, prospective, single-arm, non-randomized trial evaluating the safety and effectiveness of the INNOVA™ Self-Expanding Bare-Metal Stent System in patients with...
-
Wright Medical Group, Inc. Appoints Chairman David D. Stevens as Interim CEO
Tuesday, April 5, 2011 - 8:30am | 43Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that its Board of Directors has appointed Chairman David D. Stevens as interim President and Chief Executive Officer, effective immediately. Mr. Stevens remains Chairman of the Board.
-
Piper Jaffray On BSX Following Platinum Trial At ACC
Tuesday, April 5, 2011 - 8:29am | 92Piper Jaffray has issued a report on Boston Scientific Corp (NYSE: BSX) after its presentation of the Platinum Trial at the American College of Cardiology. According to the report, "While the solid clinical results were largely expected, it should set the stage for U.S. FDA approval of Promus...
-
Wright Medical Halted For News Pending (WMGI)
Tuesday, April 5, 2011 - 8:28am | 16Wright Medical Halted For News Pending (NASDAQ: WMGI)
-
Trading Halted: Wright Medical Group, News Pending (WMGI)
Tuesday, April 5, 2011 - 8:26am | 17Trading Halted: Wright Medical Group (NASDAQ: WMGI), News Pending
-
Piper Jaffray Reports Solid Efficacy On Medtronic
Tuesday, April 5, 2011 - 7:58am | 149According to Piper Jaffray, Medtronic's (NYSE: MDT) Resolute results show solid efficacy in a pivotal study. Piper Jaffray reported that results from Medtronic's U.S. pivotal trial evaluating the safety and efficacy of the Resolute drug eluting stent were presented this morning at the American...
-
Morgan Stanley Reports Medtronic Endeavor Potential Underapreciated
Tuesday, April 5, 2011 - 7:51am | 130According to Morgan Stanley, Medtronic (NYSE: MDT) endeavor potential is underappreciated. Morgan Stanley reported that RESOLUTE US data showed encouraging efficacy results and a very low rate of stent thrombosis that directly addressed safety concerns on prior data. “The study was non-randomized...
-
Alphatec Receives FDA Approval For Solus Reports Jefferies
Tuesday, April 5, 2011 - 7:49am | 89Alphatec Holdings (NASDAQ: ATEC) has been granted FDA approval for Solus, an anterior interbody fusion device produced by the company, says Jefferies. In its report, Jefferies writes, “The approval of Solus gives ATEC a unique entrant into the $350mn US market for standalone ALIF devices. It is...